Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · Real-Time Price · USD
3.010
+0.280 (10.26%)
At close: Jun 26, 2026, 4:00 PM EDT
3.038
+0.028 (0.94%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Jaguar Health Employees
Jaguar Health had 47 employees as of December 31, 2025. The number of employees decreased by 2 or -4.08% compared to the previous year.
Employees
47
Change (1Y)
-2
Growth (1Y)
-4.08%
Revenue / Employee
$629,128
Profits / Employee
-$1,066,511
Market Cap
1.82M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valion Bio | 52 |
| Scinai Immunotherapeutics | 45 |
| Calidi Biotherapeutics | 29 |
| Virax Biolabs Group | 19 |
| Silexion Therapeutics | 14 |
| VivoSim Labs | 14 |
| Azitra | 13 |
| Biodexa Pharmaceuticals | 11 |
JAGX News
- 3 days ago - Jaguar Health announces conversion of Series O convertible preferred stock - TheFly
- 3 days ago - Jaguar Health Announces Conversion of Series O Convertible Preferred Stock Issued as Recent One-time Stock Dividend - Accesswire
- 4 days ago - Jaguar Health Transcript: Life Sciences Virtual Investor Forum - Transcripts
- 5 days ago - Jaguar Health completes submission of NADA to U.S. FDA for crofelemer - TheFly
- 5 days ago - Jaguar Health Completes Submission of New Animal Drug Application for Full FDA Approval of Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs - Accesswire
- 6 days ago - Jaguar Health initiates process to explore, review strategic alternatives - TheFly
- 6 days ago - Jaguar Health Announces Plan to Explore Strategic Alternatives Aligned with Targeted NDA Filing for Rare Disease Intestinal Failure Program - Accesswire
- 10 days ago - Magdalena Biosciences announces results from preclinical study of coca - TheFly